Riskpilot← Back to searchSign inGet full accessK&O Lyckenblad AB
ABActiveOrg 5594284381Eklanda Vall 111General medical practice activities · NACE 8621Est. 20230 employees
Revenue 2025
SEK 71K
-24% vs 2024
EBITDA margin
75.5%
-12% vs 2024
Equity ratio
80.2%
Financial strength
Net profit 2025
SEK 43K
-14% vs 2024
| Revenue | SEK 71K | -24% |
| EBITDA | SEK 54K | -12% |
| Net profit | SEK 43K | -14% |
| Total assets | SEK 140K | +50% |
| Equity | SEK 112K | +61% |
| Employees | 0 | — |
Legal name
K&O Lyckenblad AB
Org number
5594284381
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
30 mars 2023
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Konsultverksamhet inom medicin, hälsa och sjukvård främst genom behandlingsuppdrag inom primärvården. Samt äga och förvalta aktier, fonder och fastigheter.
Address
Eklanda Vall 111
Email
oskar.lyckenblad@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 0 | 94 | 71 |
| Staff expenses | — | — | −6 |
| EBITDA | −6 | 61 | 54 |
| Depreciation & amort. | — | — | — |
| EBIT | −6 | 61 | 54 |
| Net financials | 0 | — | — |
| Profit before tax | −5 | 61 | 54 |
| Tax | — | −11 | −11 |
| Net profit | −5 | 50 | 43 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 20 | 93 | 140 |
| Equity | 20 | 69 | 112 |
| Long-term debt | — | — | — |
| Short-term debt | 1 | 24 | 28 |
| Total debt | 1 | 24 | 28 |
EBITDA margin
75.5%
This company
15.8%
Market median
+378% vs market
20232025
Equity ratio
80.2%
This company
38.2%
Market median
+110% vs market
20232025
Return on equity
38.1%
This company
18.4%
Market median
+107% vs market
20232025
Net profit margin
60.0%
This company
8.1%
Market median
+641% vs market
20232025
Asset turnover
0.51×
This company
1.12×
Market median
-54% vs market
20232025
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20232025
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KV Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2023 | |
| Deputy Board Member | 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of K&O Lyckenblad AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Klara Viktoria Hulweg Lyckenblad | Deputy Chief Executive Officer | 0 companies |
| Oskar Hans Peter Lyckenblad | Chairman | 0 companies |
| Greta Lovisa Hulweg Lyckenblad | Deputy Board Member | 0 companies |